A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia
NCT: NCT06580405 · NOT_YET_RECRUITING
Brief Summary
The study will primarily evaluate safety of the KNP-1000 apheresis system for pregnant women and their fetuses diagnosed with preeclampsia with severe features between 23- and 32-weeks' gestation (very preterm).
Frequently Asked Questions
What is A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia?
A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia is a clinical trial registered under NCT06580405. Current status: NOT_YET_RECRUITING.
What is the status of NCT06580405?
The current status of NCT06580405 (A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia) is: NOT_YET_RECRUITING.
When did A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia start?
A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia started on 2026-10-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.